NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/24/2024
Back to search
Official data from USPTO
V VETTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/24/2024
Trademark type
Combined
Nice classes
5, 7, 10, 42
Filing date
05/08/2013
Registration date
02/11/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2024
Last transaction
01/24/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
RAVENSBURG, DE
Examiner
HWANG, JOHN
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a letter "V" with a circle above the letter and the term "VETTER" below the letter. A horizontal line is above "VETTER" and below the "V" and is intersected by the bottom point of the letter "V".
Holders and representatives
Holders
VETTER PHARMA-FERTIGUNG GMBH & CO. KG
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Representatives
M. Scott Alprin Alprin Law Offices, P.C.
Technical classification
Nice Classes
Class 5Class 7Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and medicamentssolutions for oral usesterile solutions and solutions for injections all for use in the treatment of infectionscancerdepressionheart diseasevascular diseasekidney diseaseintestinal disorderlung and bronchial disorderliver dysfunctionoral and laryngeal diseaseoptical and cranial disorders; pharmaceutical preparations containing heparinsvaccinescalcitoninsprostaglandinsanaesthesticsreconstruction diluentshuman growth hormonemonoclonal antibodiesepourokinasefactor VIIIgnrh analogsrecombinant proteins eye dropssolutions for contact lenses all for use in the treatment of infectionscancerdepressionheart diseasevascular diseasekidney diseaseintestinal disorderlung and bronchial disorderliver dysfunctionoral and laryngeal diseaseoptical and cranial disorders; fillings of liquidsemi-solid or solid substancespharmaceutical preparations in solvated form as solutions with active agentsas powders with solvent or as lyophilistates with solvent in injection systemsin injection syringes and instruments for infectionsinjectorsinjector pens as well as in single chamberdouble chamber and disposable syringesas well as solutions for oral use as well as sterile solutionssolutions for injections including aseptic filling of injection solutions all for use in the treatment of infectionscancerdepressionheart diseasevascular diseasekidney diseaseintestinal disorderlung and bronchial disorderliver dysfunctionoral and laryngeal diseaseoptical and cranial disorders; preparations containing heparinsvaccinescalcitoninsprostaglandinsanaesthesticsreconstruction diluentshuman growth hormonemonoclonal antibodiesepourokinasefactor VIIIgnrh analogsrecombinant proteins all for use in the treatment of infectionscancerdepressionheart diseasevascular diseasekidney diseaseintestinal disorderlung and bronchial disorderliver dysfunctionoral and laryngeal diseaseoptical and cranial disorders; tampons with and without disinfectants and bandages separately or jointly packedin sterile packages
Class 7
Machine toolsmotorscouplings and clutchesdrive beltsfilling machineslabeling machines packaging machinesbox-making machines ALL for erectingfilling and closing of cardboard and foldable boxes; machines for washingfilling and closing medical syringes and vials; INDUSTRIAL robots; mechanical transport machines for the transfer of containers between processing stationsthermoforming machines for producingfilling and sealing of blister packaging; and machines for controlling the supply and filling of goods in containers
Class 10
Medical injection systemssyringes and instruments for injectionsinjectorsinjection pens auto-injectors as well as single chamber and double chamber disposable syringesall sold empty; containers for medicaments made from glass and/or plastics and syringe holders for ready-to-use syringes for picking-up and handling of syringes
Class 42
Design and development of injection syringes and instruments and injectors and corresponding packages; chemical and microbiological analyses for scientific and forensic research purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/24/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/24/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/23/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/11/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/06/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/29/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/03/2020
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/02/2020
E815
TEAS SECTION 8 & 15 RECEIVED
02/07/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2013
PUBO
PUBLISHED FOR OPPOSITION
11/26/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/18/2013
ALIE
ASSIGNED TO LIE
10/17/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
10/02/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/02/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
10/02/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/02/2013
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/30/2013
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/30/2013
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
08/30/2013
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
08/30/2013
DOCK
ASSIGNED TO EXAMINER
08/26/2013
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/15/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2013
NWAP
NEW APPLICATION ENTERED
05/11/2013
Continuous trademark protection
Get notified about every new filing that threatens V VETTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.